Dyed vs. Undyed Polyglactin Sutures in Cutaneous Surgery
Launched by WEST VIRGINIA UNIVERSITY · Jul 11, 2025
Trial Information
Current as of August 19, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who are scheduled for a standard of care surgical excision
- Exclusion Criteria:
- • Patients who are unable to give informed consent
About West Virginia University
West Virginia University (WVU) is a leading research institution dedicated to advancing healthcare through innovative clinical trials and research initiatives. With a strong commitment to improving patient outcomes, WVU harnesses its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies across a wide range of medical fields. The university collaborates with healthcare providers, industry partners, and regulatory bodies to ensure the highest standards of ethics and scientific integrity in its research endeavors. WVU strives to translate scientific discoveries into practical applications, ultimately enhancing the quality of care for diverse populations in West Virginia and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Waynesburg, Pennsylvania, United States
Patients applied
Trial Officials
Sarah Camplbell, MD
Principal Investigator
West Virginia University-Dermatology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported